1 Min Read
April 10 (Reuters) - Invictus MD Strategies Corp:
* INVICTUS’ ACREAGE PHARMS ACQUIRES 23 NEW STRAINS, EXPANDING ITS GENETICS PROFILE Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.